(Q53235329)

12 May 2018

title

Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice. (English)

1 reference

12 May 2018

author name string

Chapman S

1

1 reference

12 May 2018

Sabo T

2

1 reference

12 May 2018

Roses AD

3

1 reference

12 May 2018

Michaelson DM

4

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

12 May 2018

published in

Neuroscience

1 reference

12 May 2018

volume

97

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

page(s)

419-424

1 reference

12 May 2018

Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

A simple and efficient method for apolipoprotein E genotype determination

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Lipoprotein receptors: signaling functions in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Expression of apolipoprotein E during nerve degeneration and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Apolipoprotein E4 in Parkinson Disease and Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Apolipoprotein E alleles as risk factors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Differential neurotrophic effects of apolipoprotein E in aged transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Apolipoprotein E genotyping by one-stage PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900087-7

7 January 2021

10.1016/S0306-4522(00)00087-7

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10828524

1 reference

12 May 2018